13.45
                                            Schlusskurs vom Vortag:
              $14.04
            Offen:
              $14.25
            24-Stunden-Volumen:
                24,823
            Relative Volume:
              0.41
            Marktkapitalisierung:
                $60.83M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-24.77M
            KGV:
              -18.42
            EPS:
                -0.73
            Netto-Cashflow:
                $-17.36M
            1W Leistung:
              -7.50%
            1M Leistung:
              -10.42%
            6M Leistung:
                +76.97%
            1J Leistung:
              +89.70%
            Mink Therapeutics Inc Stock (INKT) Company Profile
Firmenname
                  
                      Mink Therapeutics Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      212-994-8250
                    
                Adresse
                  
                      149 FIFTH AVENUE, NEW YORK
                    
                Vergleichen Sie INKT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                INKT
                            
                             
                        Mink Therapeutics Inc 
                           | 
                    13.45 | 63.50M | 0 | -24.77M | -17.36M | -0.73 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Mink Therapeutics Inc Stock (INKT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-08-15 | Hochstufung | H.C. Wainwright | Neutral → Buy | 
| 2025-07-14 | Herabstufung | William Blair | Outperform → Mkt Perform | 
Mink Therapeutics Inc Aktie (INKT) Neueste Nachrichten
Can trapped investors hope for a rebound in MiNK Therapeutics Inc.Portfolio Update Summary & Community Consensus Trade Alerts - newser.com
How MiNK Therapeutics Inc. (6Q40) stock compares with tech leaders2025 Market Outlook & Weekly Top Gainers Alerts - newser.com
How to monitor MiNK Therapeutics Inc. with trend dashboardsJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
Candlestick signals on MiNK Therapeutics Inc. stock todayJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com
MiNK Therapeutics Inc. recovery potential after sell offQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock inflation resilient2025 Top Decliners & AI Driven Stock Reports - newser.com
Can MiNK Therapeutics Inc. stock resist sector downturnsBull Run & Fast Momentum Entry Tips - newser.com
How resilient is MiNK Therapeutics Inc. stock in market downturnsTrade Analysis Summary & Safe Capital Growth Trade Ideas - newser.com
Can MiNK Therapeutics Inc. recover in the next quarterProduct Launch & Comprehensive Market Scan Reports - newser.com
Will MiNK Therapeutics Inc. stock benefit from sector rotationJuly 2025 Movers & Breakout Confirmation Trade Signals - newser.com
Using fundamentals and technicals on MiNK Therapeutics Inc.2025 Top Decliners & Low Risk Growth Stock Ideas - newser.com
Published on: 2025-11-03 01:49:46 - newser.com
Published on: 2025-11-02 23:27:12 - newser.com
Detecting price anomalies in MiNK Therapeutics Inc. with AIEarnings Miss & Weekly Breakout Stock Alerts - newser.com
Why analysts remain bullish on MiNK Therapeutics Inc. stockTreasury Yields & AI Powered Market Entry Strategies - newser.com
Why MiNK Therapeutics Inc. stock could see breakout soonEarnings Recap Report & Daily Profit Maximizing Tips - newser.com
MiNK Therapeutics Inc. stock outlook for YEARGDP Growth & Stepwise Trade Execution Plans - newser.com
How MiNK Therapeutics Inc. (6Q40) stock moves on employment data2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
Is MiNK Therapeutics Inc. stock safe for conservative investors2025 Earnings Surprises & Capital Efficiency Focused Strategies - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock bottoming after sell offTrade Risk Report & Community Consensus Stock Picks - newser.com
What MACD signals say about MiNK Therapeutics Inc.Quarterly Profit Summary & Long Hold Capital Preservation Tips - newser.com
Published on: 2025-11-02 11:54:11 - newser.com
Published on: 2025-11-02 02:51:55 - newser.com
Published on: 2025-11-02 02:18:51 - newser.com
Earnings visualization tools for MiNK Therapeutics Inc.July 2025 Summary & Trade Opportunity Analysis Reports - newser.com
Published on: 2025-11-01 08:48:26 - newser.com
How to build a custom watchlist for MiNK Therapeutics Inc.Earnings Summary Report & Stepwise Trade Signal Implementation - newser.com
Published on: 2025-10-31 04:18:27 - newser.com
Will MiNK Therapeutics Inc. (6Q40) stock see insider accumulationWeekly Stock Recap & Expert Verified Stock Movement Alerts - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock undervalued historicallyGap Down & Risk Adjusted Buy and Sell Alerts - newser.com
Published on: 2025-10-31 01:41:32 - newser.com
What’s next for MiNK Therapeutics Inc. stock priceJuly 2025 Setups & High Conviction Investment Ideas - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock safe for risk averse investorsAnalyst Downgrade & Entry Point Confirmation Signals - newser.com
Published on: 2025-10-31 00:49:49 - newser.com
Finanzdaten der Mink Therapeutics Inc-Aktie (INKT)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):